Semaglutide: A New Option to Protect Heart Health in Greenwich
Semaglutide is a weekly injection designed to be prescribed alongside a healthy diet, increased physical activity, and other medications such as statins or blood pressure treatments. This means eligible patients will receive a coordinated approach to managing their heart and circulatory health, helping reduce preventable hospital visits and serious complications.
For local residents, this is particularly significant. Cardiovascular disease affects many in the community, and interventions that combine medication with lifestyle support can dramatically improve long-term health outcomes. Clinical trials have shown semaglutide can prevent serious events like heart attacks and strokes in people with overweight or obesity, providing a new layer of protection for those already at higher risk.
Eligibility is specific: adults with a BMI of 27 or higher who have experienced a heart attack, stroke, or peripheral arterial disease. Patients will typically be referred through GPs or specialist services for assessment and prescription.
Greenwich residents concerned about heart health should speak to their GP to check whether they meet the criteria. Local weight management services and cardiovascular support programs can also offer guidance, helping people combine medical treatment with sustainable lifestyle changes.
Semaglutide represents a step forward in the NHS’s 10-Year Health Plan, providing residents with a practical, evidence-based tool to prevent serious heart problems and improve quality of life.
Speak with your GP or pharmacist today!
